22nd North American ISSX Meeting – Montréal, Canada (15th-19th July)

Dr Colin Brown will be attending the 22nd North American Meeting of the International Society for the Study of Xenobiotics between 15 – 19 July 2018 in Montréal, Québec, Canada.

The meeting brings together individuals who are working on drug/xenobiotic research across a diverse range of fields such as clinical pharmacology and therapeutics, toxicology, oncology, endocrinology, physiology, biochemistry, medicinal chemistry, molecular and structural biology and genetics.

Two posters will be available for viewing between 16th-18th July in the Exhibition Hall. This will form part of the 2nd poster session on Tuesday 17th July from 12-2pm:  

Characterization of Cisplatin Toxicity in aProximateTM Human Proximal Tubule Cell Monolayers

Development of a Novel Predictive In Vitro Non-Human Primate Proximal Tubule Model for Drug Transporter and Nephrotoxicity Studies

Information of the aProximateTM assay will also be available throughout the meeting on the Solvo Biotechnology stand (Booth 210)

If you are attending the 22nd North American ISSX Meeting and would like to arrange a meeting with Dr Brown, to learn more about our product and services, then please let us know – https://newcellsbiotech.co.uk/collaborate

You might also be interested in…
News

Development of functioning in vitro lung assay for modelling Covid-19 infection

Newcells Biotech, experts in induced pluripotent stem cell (iPSC) differentiation and assay construction, have confirmed their human lung epithelium model as an effective platform for modelling SARS-CoV-2 infection and replication.  Their work alongside the Liverpool School of Tropical Medicine (LTSM) Centre for Drugs and Diagnostics will be crucial in helping

The Biosphere
News

Newcells Biotech scales up its operations in The Biosphere

Newcells Biotech, a pioneering life-sciences spin-out that applies Human induced Pluripotent Stem Cells (hiPSCs) to develop assays for drug development, have consolidated their two laboratory sites into 500m2 of laboratory and co-located office space in The Biosphere, which forms part of the Newcastle Helix cluster.    The purpose-built space in the city centre site

COVID-19 Vaccine
Blog

An Overview of Vaccine Development & Sub-Types

Vaccination can be regarded as one of biomedicines biggest triumphs. Since Edward Jenner pioneered the smallpox vaccine in 1798, subsequent morbidity and mortality rates have declined for a multitude of diseases, such as Diphtheria, Whooping Cough and Measles.1 However, despite the success of these global vaccination